603108.SHG Shanghai Runda Med Tech Co
- Market cap
- CNY 6.16B
- P/E
- -
- P/B
- 1.63x
- ROE
- -6.4%
- Dividend yield
- 4.57%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603108.SHG undervalued?
Graham numberThe Graham number of Shanghai Runda Med Tech Co cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Runda Med Tech Co fundamental analysis
No fundamental analysis for Shanghai Runda Med Tech Co yet.
Shanghai Runda Med Tech Co stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It provides laboratory design/renovation, laboratory standardization, and information management system services; various customized laboratory management solutions; professional technical services; and specialized logistic services. The company also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents a…
Full company profileShanghai Runda Med Tech Co financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Runda Med Tech Co annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.16B | 4.32B | 5.96B | 7.05B | 7.07B | 8.86B | 10.5B | 9.15B | 8.31B | 7.00B | 6.39B |
| Gross Profit | 608M | 1.21B | 1.64B | 1.91B | 1.91B | 2.39B | 2.93B | 2.42B | 2.10B | 1.50B | 1.50B |
| Operating Income | 174M | 381M | 578M | 677M | 644M | 778M | 816M | 647M | 354M | 205M | 336M |
| EBITDA | 314M | 641M | 942M | 1.07B | 1.04B | 1.24B | 1.29B | 1.03B | 873M | 180M | 184M |
| Net Income | 116M | 219M | 262M | 310M | 330M | 380M | 418M | 273M | 55.3M | -548M | -231M |
| EPS | 0.23 | 0.38 | 0.45 | 0.53 | 0.57 | 0.64 | 0.70 | 0.47 | 0.09 | -0.91 | -0.38 |
| Balance Sheet | |||||||||||
| Total Assets | 4.11B | 7.13B | 7.54B | 9.03B | 10.2B | 12.0B | 14.5B | 14.3B | 14.3B | 13.4B | 12.4B |
| Total Liabilities | 1.89B | 4.38B | 4.41B | 5.52B | 6.10B | 7.62B | 9.51B | 8.86B | 8.70B | 8.54B | 7.83B |
| Shareholders' Equity | 2.12B | 2.29B | 2.51B | 2.76B | 3.20B | 3.46B | 3.89B | 4.28B | 4.35B | 3.79B | 3.60B |
| Cash & Short-term Investments | 920M | 550M | 373M | 964M | 1.00B | 1.05B | 1.11B | 1.13B | 1.29B | 1.02B | 627M |
| Total Debt | 1.29B | 2.96B | 2.42B | 3.07B | 4.49B | 5.69B | 6.86B | 6.85B | 5.89B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -125M | -87.9M | 539M | 247M | 323M | 371M | -429M | 802M | 647M | 637M | - |
| Capital Expenditure | 288M | 346M | 264M | 289M | 332M | 301M | 272M | 320M | 229M | 250M | 161M |
| Free Cash Flow | -414M | -434M | 274M | -42.0M | -8.50M | 70.0M | -701M | 410M | 418M | 387M | 805M |
| Ratios | |||||||||||
| ROE | 5.5% | 9.6% | 10.5% | 11.2% | 10.3% | 11.0% | 10.7% | 6.4% | 1.3% | -14.5% | -6.4% |
| ROA | 2.8% | 3.1% | 3.5% | 3.4% | 3.2% | 3.2% | 2.9% | 1.9% | 0.4% | -4.1% | -1.9% |
| Net Profit Margin | 5.4% | 5.1% | 4.4% | 4.4% | 4.7% | 4.3% | 4.0% | 3.0% | 0.7% | -7.8% | -3.6% |
| Debt to Equity | 0.61x | 1.30x | 0.97x | 1.11x | 1.40x | 1.64x | 1.77x | 1.60x | 1.35x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Runda Med Tech Co dividends
- Dividend yield
- 4.57%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jul 18, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 281M | 0.47 | - |
| 2024 | CNY 337M | 0.55 | 610.2% |
| 2023 | CNY 378M | 0.65 | 138.1% |
| 2022 | CNY 66.1M | 0.11 | 15.8% |
| 2021 | CNY 66.1M | 0.11 | 17.4% |
| 2020 | CNY 226M | 0.39 | 68.5% |
| 2019 | CNY 55.1M | 0.09 | 17.8% |
| 2018 | CNY 227M | 0.39 | 86.7% |
| 2017 | CNY 108M | 0.19 | 49.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 18:10 on Jun 1, 2017.
Who owns Shanghai Runda Med Tech Co
- Insiders 32.86%
- Institutions 1.83%
- Public & others 65.31%
- Shares outstanding 605M
- Free float 432M
Shanghai Runda Med Tech Co company profile
- Company name
- Shanghai Runda Med Tech Co
- Ticker
- 603108.SHG
- ISIN
- CNE100002318
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Employees
- 2,945
- Fiscal year end
- December
- Address
- Xinghui Center Tower 1, Shanghai, China, 200085
- Phone
- 86 21 5108 6726
- Website
- rundamedical.com
About Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It provides laboratory design/renovation, laboratory standardization, and information management system services; various customized laboratory management solutions; professional technical services; and specialized logistic services. The company also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables. In addition, it is involved in the software development; provision of information system integration and consulting services; sale of medical devices; rental services; maintenance of electronic and mechanical equipment; import and export of technology; general cargo warehousing and road freight transportation; and wholesale of pharmaceuticals. The company was incorporated in 1999 and is headquartered in Shanghai, China.
Shanghai Runda Med Tech Co management
2- Mr. Shang Lin LiaoChief Financial Officer · born 1984
- Nasheng LiAccounting Supervisor